US 10808020
Nuclease-mediated regulation of gene expression
granted A61KA61K38/00A61P
Quick answer
US patent 10808020 (Nuclease-mediated regulation of gene expression) held by Sangamo Therapeutics, Inc. expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/00, A61P, A61P43/00, A61P7/00